Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor for AVF Patency in Hemodialysis
NCT02335099Phase 2Completed
- Sponsor
- University of Virginia
- Start
- Dec 2014
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in Vascular access stenosis comparing Ticagrelor Arm with Placebo Arm (2 arms). Primary endpoint: Feasibility and Safety of Ticagrelor in Hemodialysis Patients at 6 months. Started Dec 2014; status: completed.
02
Drugs
ticagrelor
03
Conditions
Vascular access stenosis
Beyond the preview
Go deeper on NCT02335099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02335099.